Risk and Innovation in Biopharma: A CEO’s Perspective

August 6, 2014
Guest Blogger

Pharmaceutical Executive

In this Applied Clinical Trials article, Kadmon CEO Dr. Sam Waksal talks about the importance of imagination for innovation, current business risks in biopharma, and applying understanding to the concept of Big Data.

In this Applied Clinical Trials article, Kadmon CEO Dr. Sam Waksal talks about the importance of imagination for innovation, current business risks in biopharma, and applying understanding to the concept of Big Data.

Click here for the article.

Related Content:

News